Comparative prospective, double‐blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of paget's disease of bone - Concepedia

Concepedia

Publication | Closed Access

Comparative prospective, double‐blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of paget's disease of bone

123

Citations

23

References

1995

Year

Christian Roux, C. Gennari, Jordi Farrerons, J. P. Devogelaer, Hindrik Mulder, H.‐P. Kruse, C Picot, Laurence Titeux, J.-Y. Reginster, Maxime Dougados

Arthritis & Rheumatism

Abstract

Tiludronate at 400 mg/day for 3 months or 6 months is more effective than the same dosage of etidronate for 6 months in the treatment of Paget's disease.

References

	Year	Citations

Page 1